Advertisement
Canada markets closed

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7324
    +0.0026 (+0.36%)
     

  • CRUDE OIL

    83.77
    +0.96 (+1.16%)
     

  • Bitcoin CAD

    88,752.91
    +1,212.81 (+1.39%)
     

  • CMC Crypto 200

    1,398.50
    +15.93 (+1.15%)
     

  • GOLD FUTURES

    2,344.60
    +6.20 (+0.27%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,816.50
    +152.00 (+0.86%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6822
    +0.0003 (+0.04%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, DOWNBEAT GDP

U.S. first-quarter GDP report prompts inflation, growth concerns among investors

Tabula Rasa HealthCare (TRHC) in Focus: Stock Moves 5.2% Higher

Zacks Equity Research
·2 min read

Tabula Rasa HealthCare, Inc. TRHC was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $52.71 –$60.96 in the past one-month time frame, witnessed a sharp increase on Thursday.

The company has seen five negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Tabula Rasa HealthCare currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Tabula Rasa Healthcare Inc. Price

Tabula Rasa Healthcare Inc. Price
Tabula Rasa Healthcare Inc. Price

Tabula Rasa Healthcare Inc. price | Tabula Rasa Healthcare Inc. Quote

ADVERTISEMENT

Investors interested in the Medical Info Systems industry may consider Cerner Corporation CERN, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cerner Corporation (CERN) : Free Stock Analysis Report
 
Tabula Rasa Healthcare Inc. (TRHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research